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Abstract The catalytic subunit of cAMP dependent protein 
kinase (cAPK) carries two stable autophosphorylated residues. 
One of them, Thr 197, resides in the so-called protein kinase 
activation segment, and needs to be phosphorylated for full 
activity and protein kinase inhibitor binding of the enzyme. While 
wild-type recombinant mammalian C-subunit, expressed in E. 
coli, can fully autoactivate itself by phosphorylation at Thr 197, 
many active site mutants lack this autophosphorylation activity, 
so that the primary effects of the mutations become obscured. 
Two active site mutants of bovine C-subunit, defective in protein 
kinase inhibitor peptide binding, were activated by wild-type 
enzyme in vivo, but could not be activated in vitro, demonstrating 
intermolecular and presumably cotranslational autophosphoryla- 
tion. The results may delineate strategies for the expression and 
mutagenesis of other protein kinases with requirements for 
activation segment phosphorylation. 
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1. Introduction 
Many members of the protein kinase family need to be 
phosphorylated for full activity at a tyrosine or threonine 
residue in the so-called activation segment between the con- 
served sequence motifs DFG and APE in Hanks subdomain 
VIII [1,2]. Expression of these kinases in E. coIi consequently 
and inevitably leads to enzymes with impaired activity, be- 
cause most kinases are not able to autoactivate themselves, 
and E. coli does not possess the required protein kinases. This 
is an enormous obstacle to studies on enzyme kinetics, site- 
directed mutagenesis, and in investigations of protein crystal- 
lization, where large amounts of pure protein are required, 
normally a major advantage of the E. coli system. Indeed, 
with one exception all protein kinases for which the crystal 
structure has been solved so far have been crystallized from 
recombinant sources and most of them in an inactive state 
because these enzymes lack the phosphorylation f their acti- 
vation segment (for review see [3]). Examples are CDK2, 
which requires a phosphorylation at Thr 16° [4], IRK, which 
requires autophosphorylation in trans at Tyr 162 [5], ERK2, 
which needs to be phosphorylated at Thr ls3 and Thr 185 [6] 
or CaMKI at Thr 177 [7]. The active state is known only for 
those kinases that do not require phosphorylation for activity, 
like CK1 [8] or PhK 7-subunit [9]. However, there is one 
exception to date. 
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The catalytic subunit of cAPK, which requires phosphory- 
lation of Thr 107 for full activity [10-12], has been crystallized 
in its fully active phospho-form [13,14]. This was possible for 
two reasons: First, sufficient amounts of pure enzyme in the 
phosphorylated active state can be obtained from mammalian 
sources to allow growth of highly ordered single crystals [14] 
and second, in E. coli the enzyme is able to autophosphorylate 
itself at residue Thr 197 [15,16], though it is still unclear 
whether this is an intra- or intermolecular event. The situa- 
tion, however, worsens seriously if the activity of the C-sub- 
unit is impaired by mutations of active site residues. Appar- 
ently, active site mutants lose their ability to autoactivate, 
making it impossible to judge the specific effect of the muta- 
tion alone. So far, no mutants of active site residues of mam- 
malian cAPK catalytic subunit have been described. 
We report here two active site mutants of bovine catalytic 
subunit which initially were unable to bind to protein kinase 
inhibitor peptide (PKI(5-24)), a property of correctly folded 
C-subunit [11]. 
Coexpression together with the wild-type nzyme in E. coli, 
but not incubation with MgATP or wild-type nzyme in vitro, 
caused mutant activity, indicating intermolecular nd presum- 
ably cotranslational phosphorylation. The results delineate 
possible strategies for the activation of other members of 
the kinase family, which have not yet been expressed in E. 
coli in fully active form due to lack of phosphorylation at
their activation segment. 
2. Materials and methods 
2.1. Mutagenesis and enzyme xpression 
Mutagenesis was performed according to Kunkel [24] in E. coli 
strains CJ236 dut-, ung- F' (BioRad), XL1Blue fecAl lac-; 
F'[laclq lacZAM15] (Stratagene) using the phagemid pBluescript 
KS(+) (Stratagene). A bovine Ca full length 1.1 kbp 5' NdelI3' Barn- 
HI fragment [17] was mutated by using the oligonucleotide primers 5'- 
AAC CAC TAC GTC ATG AAG AT (GCC ~ GTC) (AlaZ°Val) and 
5'-CG TTC CTT GAC AAA CTC G (GTC--* GAC) (Vall°4Asp). For 
enzyme expression strain BL21(DE3)LysS F, ompT hsdSB(r~m~) 
(DE3) pLysS(Cm rt) (Novagen) and plasmids pT7-7 (Ap R) (Stanley 
Tabor, Harvard Medical School, Boston, or pET-28b(+) (KanR) (No- 
vagen, Madison) were used. In the pET-28b(+) vector the Ca gene 
was fused in frame to a sequence coding for Met-Gly-Ser-Ser-His(6)- 
Ser-Ser-Gly-Leu-Val-Pro-Arg-Gly-Ser-His--Met (His-tag). The fol- 
lowing C-subunit forms were used in this study: wild-type: rCc~WT, 
rCc~WT-His; mutants: rCa(Ala7°Val), rCc~(AlaV°Val)-His, 
rCc~(Vall°4Asp), rCa(Vall°4Asp)-His. Bacteria were grown in L-broth 
containing chloramphenicol (30 I.tg/ml) and carbenicillin (50 I.tg/ml), 
and/or kanamycin (50 gg/ml) to an OD660 of 0.6 and induced for 
protein expression at 24°C for 16 h in the presence of 0.4 mM IPTG 
to an OD660 of 2-3. 
2.2. PKI(5-24) affinity chromatography 
Kinase expressing cells were collected and resuspended toan OD660 
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of 40 in 50 mM KC1, 1 mM EDTA, 1 mM DTT, 30 mM MES, pH 
6.45. Cells were broken, and centrifuged at 80000×g for 45 min. To 
the supernatant 2 mM ATP, 3 mM MgC12 and 0.1% CHAPS were 
added for affinity chromatography on protein kinase inhibitor peptide 
PKI(5-24), coupled to Affigel 10 (BioRad) (modified from [18]). 
About 10 ml supernatant were incubated with 1 ml affinity matrix 
for 1 h. After washes in TMN (50 mM and 250 mM NaC1, 400/aM 
ATP, 2 mM MgC12, 0.1% Chaps, 20 mM Tris-Cl, pH 7.4), catalytic 
subunit was eluted with 200 mM arginine, 50 mM NaC1, 1 mM 
EDTA, 0.1% CHAPS, 20 mM Tris-C1, pH 7.4. 
2.3. Nickel chelate affinity chromatography 
His-tagged protein was separated from unmodified protein in the 
PKI(5-24) eluates using a Ni2+-loaded His.Bind resin column (Nova- 
gen) after exchanging the buffer against binding buffer according to 
the protocol of the supplier and eluted with buffer containing 1 M 
imidazole. For the NI 2+ affinity purification of His-tagged Ca-mutant 
protein directly from cell extracts, ceils were resuspended to OD660 40 
in binding buffer, broken, and centrifuged as before. 10 ml of the 
supernatant were added to 1 ml Ni 2+ chelate matrix. After washing 
with binding buffer and wash buffer with 30 mM imidazole the fusion 
proteins were eluted with 100 mM imidazole, 500 mM NaC1, 20 mM 
Tris-C1, pH 7.9. 
2.4. In vitro approach for activation of mutant enzyme 
The buffer of eluates from the Ni 2+ affinity column was exchanged 
for 150 mM LiC1, 1 mM DTT, 0.1 mM EDTA, 100 mM MOPS- 
NaOH, pH 6.8. After adding 2 mM ATP and 3 mM MgCI2 the 
protein solution, containing approx. 50 ~tg/ml C-subunit, was incu- 
bated at 30°C for 20 min to 3 h. Alternatively, catalytic amounts (0.5 
~tg/ml) of native bovine catalytic subunit were added to this mixture. 
After incubation the solution was diluted 2-fold in H20 (2 mM ATP, 3 
mM MgCI2) and subjected to PKI(5-24) affinity chromatography as 
described. 
2.5. Protein kinase assays 
Phosphorylation reactions were carried out for 3 min at 30°C in a 
mixture (100/al) containing 50 mM MOPS (morpholinopropanesulfo- 
nic acid), pH 6.8, 10 mM MgAc, 20 ng enzyme, 0.5-2 ~tCi [?-a2p]ATP, 
Kemptide substrate (Sigma) and ATP as indicated. The reactions were 
initiated by the addition of ATP and terminated by pipetting of 80 ~tl 
reaction mixture on Whatman P81 phosphocellulose paper (2 × 2 cm) 
(modified from [19]) Afterwards the paper squares were washed four 
times with 30% acetic acid. The amount of radioactive phospho- 
Kemptide was determined by liquid scintillation counting of the pa- 
pers in 4 ml scintillation fluid (Zinsser Aquasafe 500). 
3. Results 
3.1. Site-directed mutagenesis and expression of  cAPK 
C-subunit 
Two mutants of cAPK bovine Ca catalytic subunit with 
exchanges of active site residues were generated. Ala 7° was 
replaced with valine, and Val TM with aspartate. Both residues 
belong to the ATP binding pocket and interact with the pu- 
rine of ATP [14,13,20]. The alanine, and the hydrophobicity 
of Val 1°4 are almost invariant, being conserved in the protein 
kinase family [1]. The coding regions of the mutant and wild- 
type DNAs were sequenced and the proteins expressed in E. 
coli, predominantly in a soluble form. Fig. 1 shows an immu- 
noblot using polyclonal antibody against Ca, and a corre- 
sponding SDS gel of purified enzymes and cellular extracts, 
(lanes 3,4 for the control without expression vector). The wild- 
type recombinant Ca proteins (lane 1,2) were purified to 
homogeneity in one step on a column with immobilized pro- 
tein kinase inhibitor peptide PKI(5-24), and shown to be 
equally active with Kemptide as a substrate (Table I). The 
His-tagged mutant proteins migrated somewhat faster than 
rCaWT-His (lanes 6,8,10,11, see also Fig. 2, lanes 14b,15). 
Comparable behavior has been observed previously and seen 
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Fig. 1. Expression of Ca mutant proteins in E. coli. (A) Western 
blot with rabbit antibodies raised against bovine Ca. (B) Parallel 
Coomassie stained SDS-polyacrylamide gel. Lanes: 1, rCaWT; indi- 
cated by arrow; 2, rCaWT-His; 3, BL21(DE3)pLysS without vec- 
tor, high speed pellet of cell extract; 4, BL21(DE3)pLysS without 
vector, supernatant of cell extract; 5, rCa(AlaZ°Val)-His and 
rCaWT coexpression, supematant of cell extract; 6, rCa(Alar°Val)- 
His single expression, supernatant of cell extract; 7, rCa(Alar°Val)- 
His and rC~(Alar°Val) coexpression, supernatant of cell extract; 8, 
rCa(AlaT°Val)-His single expression, Ni 2+ chelate affinity chromato- 
graphy; 9, rCa(Vall°4Asp)-His and rCc~WT coexpression, superna- 
tant of cell extract; 10, rCa(Vall°4Asp)-His single expression, super- 
natant of cell extract; 11, rCa(Vall°4Asp)-His ingle expression, 
Ni 2+ chelate affinity chromatography. 
as an indication of Thr 19r being unphosphorylated [11,21]. 
Steinberg et al. [11] observed, after short-term expression of 
the mouse Ca protein in E. coli, a fast form of the enzyme 
which did not contain threonine phosphate and did not bind 
to a PKI(5-22) affinity column. The active site mutants 
rCa(AlaT°Val)-His and rCa(Vall°4Asp)-His, when singly ex- 
pressed, also did not bind to the PKI(5-24) affinity column 
(Fig. 3, lanes 7,12). This could be a primary effect of the 
mutations introduced or a secondary effect due to inability 
of the mutant enzymes to autophosphorylate at Thr a97, there- 
by obscuring the primary effect of the mutation. Singly ex- 
pressed mutants were enriched on a Ni 2+ chelate affinity col- 
umn (Fig. 1, lanes 8,9, see also Fig. 3, lanes 6,11). 
3.2. Attempts to restore kinase activity 
We suspected that the absence of Thr 197 phosphorylation 
was responsible for the deficiency in peptide binding of the 
mutant enzymes, therefore we tried to activate the mutant 
enzymes in vitro. The mutant rCa(Alar°Val)-His, enriched 
on a Ni 2+ affinity column (to minimize secondary effects of 
E. coli proteins, Fig. 1, lane 8, Fig. 3, lane 6), was incubated in 
the presence of 2 mM MgATP (Fig. 2, lanes 1,4). As this did 
not induce PKI(5-24) binding (lanes 2,3,5,6) an attempt was 
made to phosphorylate the mutant by catalytic amounts (0.5 
~tg/ml) of native bovine heart catalytic subunit in the presence 
of 2 mM MgATP. Even after 3 h incubation the mutant en- 
zyme did not gain significant PKI(5-24) binding (lanes 8-13). 
The viability of the wild-type enzyme in the activation assay 
was verified in a subsequent kinase assay with Kemptide as a 
substrate (not shown). In contrast o the results with mouse 
wild-type enzyme lacking a Thr 197 phosphate [11], the rCa- 
(AlaT°Val)-His mutant protein did not convert o a slow mi- 
grating form under these conditions. This could indicate that 
the mutant has not been phosphorylated intermolecularly at
Thr 197 in vitro, or that it did not change its migration behav- 
ior in the SDS gel or acquire the ability to bind to the 
PKI(5-24)-column. Lanes 15-18 of Fig. 2 show the negative 
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Km values of wild-type and mutant proteins for MgATP and Kemp- 
tide 
Km MgATP (I.tM) Km Kemptide (laM) 
rC~WT 9.1 +_ 0.9 5.4 + 0.3 
rCc~WT-His 9.6 + 0.5 5.3 + 0.4 
rCct(Alar°Val)-His 167 + 14 162 + 27 
rC~(Vall°4Asp)-His 202 + 33 220 + 39 
The phosphorylation reaction for determination f Km MgATP con- 
tained 50 ~tM Kemptide, when wild-type enzyme was measured, and 
250 ktM Kemptide, when the mutants were measured. For measure- 
ment of Km Kemptide the phosphorylation reaction contained 100 
~tM ATP, and 200 laM ATP, when the mutants were measured. 
control at time points to and t3h in the absence of both 
MgATP and native Cot; lanes 20-22 show the positive control 
where purified protein from a coexpression experiment of 
rCtx(Ala7°Val)-His and rC~WT (see the next paragraph) has 
been added to the Ni 2+ chelate affinity eluate of singly ex- 
pressed rCt~(Ala7°Val)-His, demonstrating that mutant and 
wild-type protein can readily be purified from these mixtures 
on the PKI(5-24) affinity column (lane 22). 
3.3. In vivo activation 
Because it could not be excluded that Thr 197 phosphoryla- 
tion of mutant enzymes requires the conditions of the living 
cell, the rCt~WT protein was coexpressed together with each 
mutant. This experiment could also provide an answer to the 
open question of whether Thr 197 autophosphorylation occurs 
intra- or intermolecularly. If exclusively intramolecular, how- 
ever, this would impair the possibilities of generating C-sub- 
unit active site mutants in E. coli in general. Fig. 3 shows that 
both mutants rCct(AlaT°Val)-His and rCa(Vap4Asp)-His 
could readily be purified on the PKI(5-24)-affinity column 
when coexpressed together with rC~tWT (lanes 4,9). Further- 
more, in contrast o the singly expressed enzymes (lanes 6,11), 
a mobility shift towards a slower migrating form was ob- 
served (lanes 5,6,10,11). Both phenomena re known to indi- 
cate phosphorylation at activation segment residue Thr 197 
[11]. The same result was achieved when the non-fusion mu- 
tant proteins (rCct(AlaT°Val) and rC~(Vall°4Asp)) were coex- 
pressed together with a wild-type His-tag fusion (not shown), 
indicating that the PKI(5-24) binding activation was indepen- 
dent from the His-tag. The rC~WT-His fusion, however, 
caused some proteolytic degradation at the N-terminus, indi- 
cated by small amounts of protein at ~ 40 kDa (see Fig. 1, 
lane 2) which could not be removed by Ni 2+ chelate affinity 
chromatography. As this would lead to unwanted contamina- 
tion of mutant protein with traces of wild-type activity, for 
further analysis only the His-tagged mutant proteins were 
used. The possibility that mutant activation could be simply 
caused by using a double vector system was excluded by co- 
expressing the fusion and non-fusion forms rCc~(AlaT°Val)- 
His and rCct(Ala7°Val) (Fig. 1, lane 7). None of the two 
proteins gained PKI(5-24) binding ability (Fig. 3, lane 8). 
Intermolecular phosphorylation of the mutant enzymes by 
the wild-type is the only plausible xplanation for activation 
of PKI-peptide binding. The activated mutant proteins from 
the coexpression experiments with rCt~WT were purified to 
homogeneity from the mixture with the wild-type enzyme on 
a Ni 2+ affinity column (Fig. 3, lanes 5,10). 
3.4. Kinetic analysis of  the activated mutants 
For both purified mutants from the coexpression experi- 
ments the kinetic constants were measured with MgATP 
and Kemptide as a substrate. Both mutants are defective in 
Km for MgATP, and Km for substrate peptide (see Table 1). 
4. Discussion and conclusions 
Several protein kinases are expressed in E. coli in an inac- 
tive or partly active form due to the absence of activation 
segment phosphorylation. Although the mammalian Ca-sub- 
unit of cAPK from mouse or bovine is well able to autophos- 
phorylate and thereby activate itself during expression in E. 
coli. studies on enzyme mechanism by site-directed mutagen- 
esis, however, are seriously hindered because the ability to 
autophosphorylate appears to be lost in active site mutants, 
+ MgATP + MgATP - MgATP 
- WT C~ + WTCCt - WTC~ 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
t20, t3h t20, t3h to t3 h 
b~ 
Fig. 2. In vitro activation approaches of active site mutant rCct(Ala7°Val)-His. Coomassie blue stained SDS polyacrylamide g l. The presence 
or absence of MgATP or native enzyme and the incubation time are indicated above the lanes; to, t20min, t3h, indicates that the Ni 2+ chelate af- 
finity enriched mutant was incubated at 30°C for O min, 20 min, and 3 h, respectively. Lanes: 7,14,19, rCctWT (a) and rCtxWT-His (b), mix- 
ture of PKI(5-24) affinity purified protein; 1,4,8,11,15,16, rCet(Ala7°Val)-His; Ni 2+ chelate affinity enriched; 2,5,9,12,17, material which re- 
mained unbound to the PKI(5-24) affinity columns; 3,6,10,13,18, elution from this PKI(5-24) affity columns; 20~22, control: 20, 
rCct(AlaV°Val)-His as above, to which about 100 ktg/ml (each) rCtx(AlaT°Val)-His and rC~WT, PKI(5~4) affinity purified protein from a coex- 
pression were added; 21, material which remained unbound to the PKI(5~4) affinity column; 22, proteins eluted from this PKI(5-24) affinity 
column. Equivalent relative proportions of samples were loaded onto the SDS gel. Faint bands visible in the PKI(5-24) eluates (lane 
3,6,10,13,18) presumably result from residual peptide binding ability of the single expressed mutant protein. 
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Fig. 3. Affinity chromatography of Cc~ active site mutants. Lanes: 
1, molecular mass marker; 2, rCaWT, single expression, PKI(5-24) 
affinity chromatography; 3, rCaWT-His, single expression, PKI(5- 
24) affinity chromatography; 4, rCa(AlaT°Val)-His and rCaWT, co- 
expression, PKI(5-24) affinity chromatography; 5, rCa(AlaT°Val) - 
His, Ni 2+ chelate affinity chromatography from rCa(AlaZ°Val)-His 
and rCcxWT coexpression (see lane 4); 6, rCa(AlaT°Val)-His, single 
expression, Ni 2+ chelate affinity chromatography; 7, rCo~(Ala7°Val) - 
His single expression, PKI(5-24) affinity chromatography; 8, rCc~(A- 
laT°Val)-His and rCo~(AlaT°Val), coexpression, PKI(5-24) affinity 
chromatography; 9, rCa(VaP°4Asp)-His and rCc~WT, coexpression, 
PKI(5-24) affinity chromatography; 10, rCa(Vall°4Asp)-His, Ni 2+ 
chelate affinity chromatography from rCa(Vall°4Asp)-His and 
rCc~WT coexpression (see lane 9); 11, rCa(Vall°4Asp)-His, ingle ex- 
pression, Ni ~+ chelate affinity chromatography; 12, rCa(Vall°4Asp)- 
His, single expression, PKI(5-24) affinity chromatography. 
and the primary effects of the mutations introduced becomes 
undetectable simply due to this effect. In our studies on active 
site mutants of the catalytic subunit of cAPK, coexpression of
the wild-type enzyme together with rCc~(AlaT°Val) or 
rCcffVap°4Asp), or several other active site mutants which 
were not shown here, induced PKI peptide binding capability, 
and allowed kinetic analysis of the primary mutational effects. 
The activation, however, could not be achieved in vitro. 
It has been shown previously that Thr 197 phosphorylation 
affects the activity state of the cAMP-dependent protein ki- 
nase [11,12]. In the crystal structure of cAPK, the Thr 197 
phosphoryl group contacts the sidechains of His sT, Arg 165, 
Lys ls9, and Thr 195 [13,14]. The contact to Arg 165, a residue 
conserved in many kinases, may be of special significance, as 
it provides an interaction with the catalytic base Asp 166. Prob- 
ably the Thr 197 phosphoryl group affects the stereochemical 
orientation of the catalytic base via Arg 165, and thus the acti- 
vation state of the enzyme. 
The results trongly suggest intermolecular phosphorylation 
as the mechanism for the activation of the mutants. The find- 
ing that this could not be achieved in vitro in the presence of 
MgATP and wild-type enzyme indicates that factors in the 
living cell may be essential for the activation process, it is 
feasible that the immature conformation of the nascent poly- 
peptide chain during translation facilitates access and phos- 
phorylation of Thr 197 in trans. For the wild-type enzyme, 
however, autophosphorylation n cis, at least in addition, can- 
not be excluded yet. 
The data are in support of a cotranslational utophosphor- 
ylation at Thr 197 for the active site mutants. Cotranslational 
intermolecular utophosphorylation of cAPK in E. coli may 
be especially sensitive to any changes in the kinetic behavior 
of the expressed enzyme. If the process is not under a specific 
control, it is possible that there are spatial and temporal lim- 
itations. Many restrictions are conceivable that require a per- 
fect enzyme to phosphorylate the nascent peptide chain: (i) 
the abundance of ATP, which may fall below the K~ of an 
ATP-mutant (both rCeffAlaT°Val)-His and rCcx(Vap°4Asp)- 
His have KmATp defects (see Table 1); (ii) the substrate recog- 
nition site, which may be accessible only for an enzyme with 
optimal peptide binding behavior, (iii) temporal limita- 
tions - a Vm~ mutant may simply not be fast enough to 
compete with the translational machinery. However, this phe- 
nomenon may be restricted to expression of cAPK or other 
kinases in bacteria like E. coil In yeast, a great number of 
mutations, including those in catalytically important residues, 
have been successfully introduced [22]. Possibly, specific con- 
trol mechanisms in the eucaryotic ell ensure the correct co- 
translational modifications of the target proteins, even when 
the enzyme acting on it is seriously impaired. On the other 
hand, in eucaryotic cells activation by a foreign protein kinase 
cannot be excluded. 
Other kinases, like Erk2, cyclin dependent kinases, protein 
kinase C, and most tyrosine kinases [3,23] require phosphor- 
ylation at activation segment residues for full activity. For 
some of these enzymes the activating kinase has not been 
identified yet. The idea that cotranslational phosphorylation 
may be required for the activation of these kinases as well 
provides the possibility of adopting the system to other en- 
zymes, and may be considered not only in order to autoacti- 
vate these enzymes, but also for coexpression of those kinases 
which are suspected of trans activation, but fail in in vitro 
assays. 
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